询 价
索取COA
产品描述
产品数据库
Introduction | ||||||
Description | DNA methylation is an epigenetic modification, a form of chemical modification of DNA, which refers to the carbon 5 of cytosine in the genomic CpG dinucleotide under the action of DNA methyltransferase. covalently bonded to a methyl group. It can change genetic expression without changing the DNA sequence. This package contains multiple detection samples for Colorectal cancer, We use simulated clinical cell lines to prepare them. If you are testing SDC2/Septin 9, you can choose this product. |
|||||
Technical Data | ||||||
Classification | Cat No. | Name | Description | Region | Methylation level | |
质控品 |
CBPE0402-1 | 结直肠癌-SDC2,Septin9阳性甲基化 | SDC2 Methylation with Positive control | Chr8:97506434-97506502(hg19) | N/A | |
Septin9 Methylation with Positive control | Chr17:75369001-75369079(hg19) | N/A | ||||
CBPE0402-2 | 结直肠癌-SDC2,Septin9阴性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
CBPE0402-3 | 结直肠癌-SDC2阴性甲基化,Septin9阳性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | 0.71% | ||
Septin9 Methylation with Positive control | Chr17:75369001-75369079(hg19) | 95.21% | ||||
CBPE0402-4 | 结直肠癌-Septin9阴性甲基化,SDC2阳性甲基化 | SDC2 Methylation with Positive control | Chr8:97506434-97506502(hg19) | 69.82% | ||
Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | 0.56% | ||||
Classification | Cat No. | Name | Description | Region | Methylation level | |
单阳SDC2-参考品 |
单阳SDC2 区段-强阳性参考品-1 |
CBPE0402-5 | SDC2强阳性甲基化参考品,Septin9阴性甲基化 | SDC2 Methylation Reference Standard with 65.00% | Chr8:97506434-97506502(hg19) | 69.82% |
Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | 0.56% | ||||
单阳SDC2 区段-强阳性参考品-2 |
CBPE0402-6 | SDC2强阳性甲基化参考品,Septin9阴性甲基化 | SDC2 Methylation Reference Standard with 10.00% | Chr8:97506434-97506502(hg19) | 9.91% | |
Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
单阳SDC2 区段-弱阳性参考品 |
CBPE0402-7 | SDC2弱阳性甲基化参考品,Septin9阴性甲基化 | SDC2 Methylation Reference Standard with 3.00% | Chr8:97506434-97506502(hg19) | N/A | |
Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
单阳SDC2 区段-检测限参考品 |
CBPE0402-8 | SDC2检测限甲基化参考品,Septin9阴性甲基化 | SDC2 Methylation Reference Standard with 1.00% | Chr8:97506434-97506502(hg19) | 1.20% | |
Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
单阳SDC2 区段-阴性参考品 |
CBPE0402-9 | 结直肠癌-SDC2,Septin9阴性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | |
Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
单阳SDC2 区段-精密度参考品 |
CBPE0402-10 | SDC2弱阳性甲基化参考品,Septin9阴性甲基化 | SDC2 Methylation Reference Standard with 3.00% | Chr8:97506434-97506502(hg19) | N/A | |
Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
CBPE0402-11 | 结直肠癌-SDC2,Septin9阴性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
Classification | Cat No. | Name | Description | Region | Methylation level | |
单阳Septin9-参考品 |
单阳Septin9 区段-强阳性参考品-1 |
CBPE0402-12 | Septin9强阳性甲基化参考品,SDC2阴性甲基化 | Septin9 Methylation Reference Standard with 90.00% | Chr17:75369001-75369079(hg19) | 95.21% |
SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | 0.71% | ||||
单阳Septin9 区段-强阳性参考品-2 |
CBPE0402-13 | Septin9强阳性甲基化参考品,SDC2阴性甲基化 | Septin9 Methylation Reference Standard with 10.00% | Chr17:75369001-75369079(hg19) | 10.90% | |
SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
单阳Septin9 区段-弱阳性参考品 |
CBPE0402-14 | Septin9弱阳性甲基化参考品,SDC2阴性甲基化 | Septin9 Methylation Reference Standard with 3.00% | Chr17:75369001-75369079(hg19) | N/A | |
SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
单阳Septin9 区段-检测限参考品 |
CBPE0402-15 | Septin9检测限甲基化参考品,SDC2阴性甲基化 | Septin9 Methylation Reference Standard with 1.00% | Chr17:75369001-75369079(hg19) | 1.36% | |
SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
单阳Septin9 区段-阴性参考品 |
CBPE0402-16 | 结直肠癌-SDC2,Septin9阴性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | |
Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
单阳Septin9 区段-精密度参考品 |
CBPE0402-17 | Septin9弱阳性甲基化参考品,SDC2阴性甲基化 | Septin9 Methylation Reference Standard with 3.00% | Chr17:75369001-75369079(hg19) | N/A | |
SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
CBPE0402-18 | 结直肠癌-SDC2,Septin9阴性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
备注 | 1. 质控品也叫准确度标准品,用于定性判断; 2. 参考品用于定性和定量的判断,其中强阳、弱阳、检测限、精密度、特异性的判定需要视具体项目而定,本产品的判定仅为内部标准; 3. 质控品用于性能评价,出厂检,试剂盒日常检测判定,参考品用于性能评价,出厂检; 4.上述产品只展示了部分结果,甲基化程度可以定制。 |
|||||
Product Information | ||||||
Intended Use | Research Use Only | |||||
Concentration | Download for COA | |||||
Purity | Download for COA | |||||
DNA electrophoresis | Download for COA | |||||
Format | Genomic DNA | |||||
Unit Size | 1ug | |||||
Storage | 2-8°C | |||||
Expiry | 36 months from the date of manufacture | |||||
Remark | The data in the instruction manual is the data of a single test, and the specific data of each batch is subject to delivery. |